Bottom line
FBTCX vs IBB: the short answer
FBTCX (Fidelity Advisor Biotechnology Fund) and IBB (iShares Biotechnology ETF) are both mutual funds.
IBB is cheaper at 0.44% vs 1.69% — a difference of $125 a year per $10,000 invested.
Over five years, FBTCX returned +6.8% a year vs +2.5% for IBB (reporting dates differ).
Updated Nov 19, 2026
FBTCX vs IBB side by side
| FBTCX | IBB | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fidelity | iShares |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 1.69% | 0.44% |
| Annual cost per $10k | $169 | $44 |
| 10-yr cost on $10k (prospectus) | $1,799 | $555 |
| Max front load | — | None |
| 12b-1 fee | 1% | 0% |
| 1-yr return | +37.5% | +28.0% |
| 5-yr return (annualized) | +6.8% | +2.5% |
| 10-yr return (annualized) | +7.7% | +4.4% |
| Best quarter | +30.3% | +26.8% |
| Worst quarter | −27.8% | −22.9% |
| Net assets (fund) | $2.2B | $5.9B |
| Number of holdings | 129 | 254 |
| Portfolio turnover | 54% | 27% |
| Returns as of | Sep 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
9 of FBTCX's top 25 holdings also appear in IBB's top 25.
| Holding | FBTCX | IBB |
|---|---|---|
| Gilead Sciences Inc | 5.70% | 7.52% |
| Alnylam Pharmaceuticals Inc | 3.62% | 5.68% |
| Insmed Inc | 3.05% | 2.95% |
| Argenx Se | 3.00% | 3.15% |
| Biogen Inc | 2.71% | 2.03% |
| Amgen Inc | 2.37% | 7.50% |
| Moderna Inc | 1.60% | 0.88% |
| Natera Inc | 1.43% | 2.11% |
| Vertex Pharmaceuticals Inc | 1.39% | 7.66% |
Source: SEC Form N-PORT
FBTCX top 10
- Abbvie Inc — 14.71%
- Gilead Sciences Inc — 5.70%
- Spyre Therapeutics Inc — 3.83%
- Alnylam Pharmaceuticals Inc — 3.62%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Insmed Inc — 3.05%
- Revolution Medicines Inc — 3.00%
- Argenx Se — 3.00%
IBB top 10
- BlackRock Funds III — 13.18%
- Vertex Pharmaceuticals, Inc. — 7.66%
- Gilead Sciences, Inc. — 7.52%
- Amgen, Inc. — 7.50%
- Regeneron Pharmaceuticals, Inc. — 5.70%
- Alnylam Pharmaceuticals, Inc. — 5.68%
- IQVIA Holdings, Inc. — 3.18%
- Argenx SE — 3.15%
- Insmed, Inc. — 2.95%
- Mettler-Toledo International, Inc. — 2.49%
FAQ
What is the difference between FBTCX and IBB?
FBTCX (Fidelity Advisor Biotechnology Fund) and IBB (iShares Biotechnology ETF) are both mutual funds. IBB is cheaper at 0.44% vs 1.69% — a difference of $125 a year per $10,000 invested.
Which is cheaper, FBTCX or IBB?
IBB has the lower expense ratio (0.44%).
Should I own both FBTCX and IBB?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.